Brian Titus Sells 12,134 Shares of Corteva, Inc. (NYSE:CTVA) Stock

Corteva, Inc. (NYSE:CTVA) insider Brian Titus sold 12,134 shares of the business’s stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $56.65, for a total transaction of $687,391.10. Following the completion of the transaction, the insider now directly owns 13,495 shares of the company’s stock, valued at approximately $764,491.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Corteva Price Performance

CTVA opened at $57.83 on Friday. Corteva, Inc. has a twelve month low of $43.22 and a twelve month high of $58.81. The firm has a market cap of $40.31 billion, a price-to-earnings ratio of 73.20, a PEG ratio of 1.50 and a beta of 0.78. The company has a current ratio of 1.51, a quick ratio of 0.97 and a debt-to-equity ratio of 0.10. The company has a fifty day simple moving average of $55.50 and a 200 day simple moving average of $50.78.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Wednesday, May 1st. The company reported $0.89 earnings per share for the quarter, beating analysts’ consensus estimates of $0.79 by $0.10. Corteva had a net margin of 3.32% and a return on equity of 6.68%. The company had revenue of $4.49 billion during the quarter, compared to analysts’ expectations of $4.65 billion. During the same period in the prior year, the company posted $1.16 EPS. The firm’s revenue for the quarter was down 8.0% on a year-over-year basis. Equities research analysts expect that Corteva, Inc. will post 2.83 EPS for the current fiscal year.

Corteva Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 18th. Shareholders of record on Tuesday, June 4th will be given a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 1.11%. The ex-dividend date is Tuesday, June 4th. Corteva’s payout ratio is 81.01%.

Institutional Trading of Corteva

A number of hedge funds have recently made changes to their positions in CTVA. CVA Family Office LLC bought a new position in Corteva during the 4th quarter valued at $25,000. Redmont Wealth Advisors LLC bought a new position in shares of Corteva during the first quarter worth about $25,000. BKM Wealth Management LLC acquired a new position in Corteva in the fourth quarter worth about $27,000. Rise Advisors LLC increased its holdings in Corteva by 2,522.2% in the first quarter. Rise Advisors LLC now owns 472 shares of the company’s stock valued at $27,000 after buying an additional 454 shares during the last quarter. Finally, NewSquare Capital LLC raised its stake in Corteva by 70.6% during the third quarter. NewSquare Capital LLC now owns 546 shares of the company’s stock valued at $28,000 after buying an additional 226 shares in the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Wall Street Analysts Forecast Growth

CTVA has been the subject of several analyst reports. Mizuho boosted their price target on Corteva from $56.00 to $61.00 and gave the company a “buy” rating in a report on Thursday, May 2nd. Wells Fargo & Company increased their target price on Corteva from $66.00 to $67.00 and gave the stock an “overweight” rating in a research report on Friday, May 3rd. Barclays raised their price target on Corteva from $55.00 to $58.00 and gave the stock an “equal weight” rating in a research note on Wednesday, April 10th. Royal Bank of Canada increased their price objective on shares of Corteva from $62.00 to $64.00 and gave the stock an “outperform” rating in a report on Monday. Finally, Loop Capital raised shares of Corteva from a “hold” rating to a “buy” rating and raised their target price for the stock from $57.00 to $65.00 in a research report on Monday, February 12th. Six analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Corteva presently has a consensus rating of “Moderate Buy” and an average price target of $63.24.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.